Arrowhead Pharmaceuticals Inc. (ARWR) shares were down -17.73% at $69.90 at the last check in pre-market trading. Arrowhead stock closed the last session at $84.96,
Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) traded up 40.33% on Wednesday after it revealed the data on the drug to treat liver disease. Arrowhead
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.